‘We’re just getting started’ in treating heart patients

Biopharmaceutical company Amarin is “just getting started” in treating cardiovascular patients, CEO John Thero told CNBC on Wednesday.

Source link

Leave a Comment

Sugary drink tax tied to drop in soda consumptionRebecca Henderson: Rucksack heart woman dies after transplant